Search

Author/Creator Sighinolfi, L.

1. Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study. (21st January 2016)

Authors:
Kovari, Helen; Sabin, Caroline A.; Ledergerber, Bruno; Ryom, Lene; Reiss, Peter; Law, Matthew; Pradier, Christian; Dabis, Francois; d'Arminio Monforte, Antonella; Smith, Colette; de Wit, Stephane; Kirk, Ole; Lundgren, Jens D.; Weber, Rainer; Powderly, B.; Shortman, N.; Moecklinghoff, C.; Reilly, ...
Journal:
Open forum infectious diseases
Issue:
Volume 3:Number 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. (April 2017)

Authors:
d'Arminio Monforte, A.; Andreoni, M.; Angarano, G.; Antinori, A.; Castelli, F.; Cauda, R.; Di Perri, G.; Galli, M.; Iardino, R.; Ippolito, G.; Lazzarin, A.; Perno, C.F.; von Schloesser, F.; Viale, P.; Castagna, A.; Ceccherini-Silberstein, F.; Cozzi-Lepri, A.; Girardi, E.; Lo Caputo, S.; Mussini, C.
Journal:
Clinical microbiology and infection
Issue:
Volume 23:Number 4(2017)
Page Start:
267.e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort. (April 2015)

Authors:
Postorino, M.C.; Prosperi, M.; Quiros-Roldan, E.; Maggiolo, F.; Di Giambenedetto, S.; Saracino, A.; Costarelli, S.; Lorenzotti, S.; Sighinolfi, L.; Di Pietro, M.; Torti, C.
Journal:
Clinical microbiology and infection
Issue:
Volume 21:Number 4(2015:Apr.)
Page Start:
386.e1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen. (February 2020)

Authors:
Di Maio, V.C.; Aragri, M.; Masetti, C.; Paolucci, S.; Bruzzone, B.; Degasperi, E.; Barbaliscia, S.; Pollicino, T.; Minichini, C.; Calvaruso, V.; Rendina, M.; Cento, V.; Teti, E.; Micheli, V.; Allice, T.; Polilli, E.; Palitti, V. Pace; Landonio, S.; Lenci, I.; Francioso, S.
Journal:
Digestive and liver disease
Issue:
Volume 52(2020)Supplement 1
Page Start:
e2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗